MedWatch Safety Alerts RSS Feed http://www.fda.gov/ en Baxter Healthcare Corporation Recalls SIGMA Spectrum Infusion Pumps with Master Drug Library and Spectrum IQ Infusion Systems with Dose IQ Safety Software for Repeat Upstream Occlusion False Alarms http://www.fda.gov/medical-devices/medical-device-recalls/baxter-healthcare-corporation-recalls-sigma-spectrum-infusion-pumps-master-drug-library-and-spectrum Software upgrades to the SIGMA Spectrum and Spectrum IQ infusion pumps are leading to an increase in false alarms for upstream occlusion. Tue, 01 Aug 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/medical-device-recalls/baxter-healthcare-corporation-recalls-sigma-spectrum-infusion-pumps-master-drug-library-and-spectrum Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of 2 Lots of Tydemy™ (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0.03mg/0.451mg and Levomefolate Calcium Tablets 0.451mg) Due to Out of Specification (OOS) Results at the 12-month Stability Time Point http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-2-lots-tydemytm-drospirenone-ethinyl Lupin Pharmaceuticals Inc. (Lupin) is voluntarily recalling two (2) lots of Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0.03mg/0.451 mg and Levomefolate Calcium Tablets 0.451 mg) to the patient (consumer/user) level due to out of specification (OOS) test results at t Mon, 31 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-2-lots-tydemytm-drospirenone-ethinyl 2023 Letters to Health Care Providers http://www.fda.gov/medical-devices/letters-health-care-providers/2023-letters-health-care-providers The FDA posts letters to health care providers about the safe use of medical devices. Mon, 31 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/letters-health-care-providers/2023-letters-health-care-providers Abbott Trifecta Valves: Potential Risk of Early Structural Valve Deterioration - Letter to Health Care Providers http://www.fda.gov/medical-devices/letters-health-care-providers/abbott-trifecta-valves-potential-risk-early-structural-valve-deterioration-letter-health-care Learn more about the issue, recommendations, FDA actions and reporting problems to the FDA Mon, 31 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/letters-health-care-providers/abbott-trifecta-valves-potential-risk-early-structural-valve-deterioration-letter-health-care 2023 Medical Device Recalls http://www.fda.gov/medical-devices/medical-device-recalls/2023-medical-device-recalls 2023 Medical Device Recalls Mon, 31 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/medical-device-recalls/2023-medical-device-recalls Baxter Issues Urgent Medical Device Correction for Spectrum V8 and Spectrum IQ Infusion Pumps with Specific Software Versions http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-urgent-medical-device-correction-spectrum-v8-and-spectrum-iq-infusion-pumps-specific Baxter International Inc. announced today it has issued an Urgent Medical Device Correction for Spectrum V8 and Spectrum IQ infusion pumps in the U.S. and Puerto Rico that have been upgraded to software versions v8.01.01 and v9.02.01. The Correction is due to an increase in reported false upstream o Mon, 31 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-urgent-medical-device-correction-spectrum-v8-and-spectrum-iq-infusion-pumps-specific GE HealthCare Recalls TruSignal SpO2 Sensors for Issues That May Reduce Defibrillation Energy, Expose Patients to Unintended Voltage, or Give Inaccurate Readings http://www.fda.gov/medical-devices/medical-device-recalls/ge-healthcare-recalls-trusignal-spo2-sensors-issues-may-reduce-defibrillation-energy-expose-patients TruSignal sensors monitor SpO2 and pulse rate. Sensor issues may impact patient care delivery including defibrillation without care providers’ knowledge. Fri, 28 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/medical-device-recalls/ge-healthcare-recalls-trusignal-spo2-sensors-issues-may-reduce-defibrillation-energy-expose-patients Abiomed Recalls All Impella Left Sided Blood Pumps for Risk of Motor Damage After Contact with Transcatheter Aortic Valve Replacement (TAVR) Stent http://www.fda.gov/medical-devices/medical-device-recalls/abiomed-recalls-all-impella-left-sided-blood-pumps-risk-motor-damage-after-contact-transcatheter The motor housing of Impella blood pumps may come into contact with TAVR distal stents, causing damage to the motor blades and impacting pump flow. Thu, 27 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/medical-device-recalls/abiomed-recalls-all-impella-left-sided-blood-pumps-risk-motor-damage-after-contact-transcatheter Abbott Recalls Amplatzer Steerable Delivery Sheath for Increased Risk of Air Embolism http://www.fda.gov/medical-devices/medical-device-recalls/abbott-recalls-amplatzer-steerable-delivery-sheath-increased-risk-air-embolism Abbott’s Amplatzer Steerable Delivery Sheath, a cardiac catheter, is being recalled for an increased risk of air embolism. Wed, 26 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/medical-device-recalls/abbott-recalls-amplatzer-steerable-delivery-sheath-increased-risk-air-embolism Intended Use of Imaging Software for Intracranial Large Vessel Occlusion - Letter to Health Care Providers http://www.fda.gov/medical-devices/letters-health-care-providers/intended-use-imaging-software-intracranial-large-vessel-occlusion-letter-health-care-providers The U.S. Food and Drug Administration (FDA) wants to increase awareness about the intended use of imaging software for intracranial large vessel occlusion or LVO. Wed, 26 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/letters-health-care-providers/intended-use-imaging-software-intracranial-large-vessel-occlusion-letter-health-care-providers Megadyne Recalls MEGA 2000 and MEGA Soft Reusable Patient Return Electrodes for Risk of Serious Burn Injuries to Patients http://www.fda.gov/medical-devices/medical-device-recalls/megadyne-recalls-mega-2000-and-mega-soft-reusable-patient-return-electrodes-risk-serious-burn MEGA Patient Return Electrodes used during monopolar electrosurgery may cause serious burn injuries to patients. Fri, 21 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/medical-device-recalls/megadyne-recalls-mega-2000-and-mega-soft-reusable-patient-return-electrodes-risk-serious-burn Use Alternative Testing Method for the Quidel Cardiovascular Inc. Quidel Triage Cardiac Panel - Letter to Health Care Providers http://www.fda.gov/medical-devices/letters-health-care-providers/use-alternative-testing-method-quidel-cardiovascular-inc-quidel-triage-cardiac-panel-letter-health The test is used to help doctors quickly diagnose when someone is experiencing a heart attack and other life-threatening injuries to the heart muscle. Wed, 19 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/letters-health-care-providers/use-alternative-testing-method-quidel-cardiovascular-inc-quidel-triage-cardiac-panel-letter-health Medtronic Recalls Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) with Glassed Feedthrough for Risk of Low or No Energy Output During High Voltage Therapy http://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-implantable-cardioverter-defibrillators-icds-and-cardiac-resynchronization-therapy Medtronic Recalls ICDs and CRT-Ds for Risk of Low or No Energy Output Tue, 18 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-implantable-cardioverter-defibrillators-icds-and-cardiac-resynchronization-therapy Quidel Cardiovascular Inc. Recalls Quidel Triage Cardiac Panels for Risk of False Negative Troponin Results that Could Cause Delayed Diagnosis or Missed Myocardial Infarction http://www.fda.gov/medical-devices/medical-device-recalls/quidel-cardiovascular-inc-recalls-quidel-triage-cardiac-panels-risk-false-negative-troponin-results QuidelOrtho Recalls Triage Cardiac Panels for False Negative Troponin Results Mon, 17 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/medical-device-recalls/quidel-cardiovascular-inc-recalls-quidel-triage-cardiac-panels-risk-false-negative-troponin-results 2023 Safety Communications http://www.fda.gov/medical-devices/safety-communications/2023-safety-communications Listing of Medical Device 2023 Safety Communications Mon, 17 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/safety-communications/2023-safety-communications Do Not Use RoyalVibe Health, CellQuicken, or Well-Being Reality Ultrasound Medical Devices: FDA Safety Communication http://www.fda.gov/medical-devices/safety-communications/do-not-use-royalvibe-health-cellquicken-or-well-being-reality-ultrasound-medical-devices-fda-safety RoyalVibe Health, CellQuicken, and Well-Being Reality medical devices are not authorized for marketing and have not been shown to be safe or effective. Mon, 17 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/safety-communications/do-not-use-royalvibe-health-cellquicken-or-well-being-reality-ultrasound-medical-devices-fda-safety Draeger Medical Recalls Oxylog 3000 Plus Emergency and Transport Ventilators for Risk of Unexpected Depleted Battery and Ventilator Stop http://www.fda.gov/medical-devices/medical-device-recalls/draeger-medical-recalls-oxylog-3000-plus-emergency-and-transport-ventilators-risk-unexpected The Oxylog 3000 Plus battery may drain and stop providing required breathing support even when the ventilator is plugged into AC power. Thu, 13 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/medical-device-recalls/draeger-medical-recalls-oxylog-3000-plus-emergency-and-transport-ventilators-risk-unexpected NOxBOX Ltd. Recalls NOxBOXi Nitric Oxide System for Manifold Failure that May Cause Gas Leaks and Interrupt Therapy to Neonates http://www.fda.gov/medical-devices/medical-device-recalls/noxbox-ltd-recalls-noxboxi-nitric-oxide-system-manifold-failure-may-cause-gas-leaks-and-interrupt NOxBOXi delivers inhaled nitric oxide therapy to neonates. If the manifold fails, therapy may be interrupted and the patient may experience oxygen desaturation. Thu, 13 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/medical-device-recalls/noxbox-ltd-recalls-noxboxi-nitric-oxide-system-manifold-failure-may-cause-gas-leaks-and-interrupt UPDATE: Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease Unlikely to Increase Risk of Mortality - Letter to Health Care Providers http://www.fda.gov/medical-devices/letters-health-care-providers/update-paclitaxel-coated-devices-treat-peripheral-arterial-disease-unlikely-increase-risk-mortality Available data no longer supports a probable late mortality risk associated with paclitaxel-coated devices used to treat femoropopliteal disease. Tue, 11 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/letters-health-care-providers/update-paclitaxel-coated-devices-treat-peripheral-arterial-disease-unlikely-increase-risk-mortality Illumina Cybersecurity Vulnerability Affecting the Universal Copy Service Software May Present Risks for Patient Results and Customer Networks: Letter to Health Care Providers http://www.fda.gov/medical-devices/letters-health-care-providers/illumina-cybersecurity-vulnerability-affecting-universal-copy-service-software-may-present-risks Illumina cybersecurity vulnerability affecting the Universal Copy Service software may impact patient health results. Fri, 07 Jul 2023 00:00:00 EDT FDA http://www.fda.gov/medical-devices/letters-health-care-providers/illumina-cybersecurity-vulnerability-affecting-universal-copy-service-software-may-present-risks